Evercore ISI lowered the firm’s price target on GE HealthCare (GEHC) to $98 from $102 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science Tools and Diagnostics, the analyst argues that FY25 guides from the life science tools group are likely to be conservative on China and Pharma, while in MedTech the firm contends that “healthy” utilization trends and a margin expansion thesis support the group.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare announces 510(k) submission for CleaRecon DL to FDA
- GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics
- RadNet’s DeepHealth expands FDA clearance for SmartMammo solution
- RadNet price target raised to $94 from $80 at Truist
- RadNet’s DeepHealth expands FDA clearance for SmartMammo solutionGE